AAAAAA
Results:
1-16
|
Results: 16
Authors:
Virgolini, I
Traub, T
Novotny, C
Leimer, M
Fuger, B
Li, SR
Patri, P
Pangerl, T
Angelberger, P
Raderer, M
Andreae, F
Kurtaran, A
Dudczak, R
Citation: I. Virgolini et al., New trends in peptide receptor radioligands, Q J NUCL M, 45(2), 2001, pp. 153-159
Authors:
Becherer, A
Vierhapper, H
Potzi, C
Karanikas, G
Kurtaran, A
Schmaljohann, J
Staudenherz, A
Dudczak, R
Kletter, K
Citation: A. Becherer et al., FDG-PET in adrenocortical carcinoma, CANC BIO R, 16(4), 2001, pp. 289-295
Authors:
Zettinig, G
Prager, G
Kurtaran, A
Passler, C
Breitenseher, M
Niederle, B
Dudczak, R
Citation: G. Zettinig et al., A man with a Tc-99m-pertechnetate-enhancing mediastinal mass, THYROID, 11(8), 2001, pp. 805-805
Authors:
Virgolini, I
Patri, P
Novotny, C
Traub, T
Leimer, M
Fuger, B
Li, SR
Angelberger, P
Raderer, M
Wogritsch, S
Kurtaran, A
Kletter, K
Dudczak, R
Citation: I. Virgolini et al., Comparative somatostatin receptor scintigraphy using In-111-DOTA-lanreotide and In-111-DOTA-Tyr(3)-octreotide versus F-18-FDG-PET for evaluation of somatostatin receptor-mediated radionuclide therapy, ANN ONCOL, 12, 2001, pp. S41-S45
Authors:
Zettinig, G
Leitha, T
Niederle, B
Kaserer, K
Becherer, A
Kletter, K
Dudczak, R
Citation: G. Zettinig et al., FDG positron emission tomographic, radioiodine, and MIBI imaging in a patient with poorly differentiated insular thyroid carcinoma, CLIN NUCL M, 26(7), 2001, pp. 599-601
Authors:
Traub, T
Petkov, V
Ofluoglu, S
Pangerl, T
Raderer, M
Fueger, BJ
Schima, W
Kurtaran, A
Dudczak, R
Virgolini, I
Citation: T. Traub et al., In-111-DOTA-lanreotide scintigraphy in patients with tumors of the lung, J NUCL MED, 42(9), 2001, pp. 1309-1315
Authors:
Li, SR
Koller, E
Valent, P
Gludovacz, D
Yang, Q
Patri, P
Angelberger, P
Dudczak, R
Virgolini, I
Citation: Sr. Li et al., Effects of vasoactive intestinal peptide (VIP) and somatostatin (SST) on lipoprotein receptor expression by A431 tumor cells, LIFE SCI, 68(11), 2001, pp. 1243-1257
Authors:
Li, SR
Peck-Radosavljevic, M
Koller, E
Koller, F
Kaserer, K
Kreil, A
Kapiotis, S
Hamwi, A
Weich, HA
Valent, P
Angelberger, P
Dudczak, R
Virgolini, I
Citation: Sr. Li et al., Characterization of I-123-vascular endothelial growth factor-binding sitesexpressed on human tumour cells: Possible implication for tumour scintigraphy, INT J CANC, 91(6), 2001, pp. 789-796
Authors:
Zettinig, G
Kaserer, K
Passler, C
Flores, JA
Niederle, B
Dudczak, R
Citation: G. Zettinig et al., Advanced insular thyroid carcinoma in a fourteen-year-old girl: Twenty-four years of follow-up, THYROID, 10(5), 2000, pp. 435-437
Authors:
Zettinig, G
Karanikas, G
Hanselmayer, G
Havlik, E
Dudczak, R
Citation: G. Zettinig et al., Radioactive contamination of contact lenses during radioiodine therapy, NUCL MED C, 21(10), 2000, pp. 955-957
Authors:
Kurtaran, A
Becherer, A
Pfeffel, F
Muller, C
Traub, T
Schmaljohann, J
Kaserer, K
Raderer, M
Schima, W
Dudczak, R
Kletter, K
Virgolini, I
Citation: A. Kurtaran et al., F-18-Fluorodeoxyglucose (FDG)-PET features of focal nodular hyperplasia (FNH) of the liver, LIVER, 20(6), 2000, pp. 487-490
Authors:
Zettinig, G
Weissel, M
Flores, J
Dudczak, R
Vogelsang, H
Citation: G. Zettinig et al., Dermatitis herpetiformis is associated with atrophic but not with goitrousvariant of Hashimoto's thyroiditis, EUR J CL IN, 30(1), 2000, pp. 53-57
Authors:
Kurtaran, A
Ofluoglu, S
Traub, T
Tribl, B
Speiser, P
Grabenwoger, F
Schima, W
Dudczak, R
Virgolini, I
Citation: A. Kurtaran et al., An unusual visualization of the gallbladder by somatostatin receptor (SSTR) scintigraphy: Usefulness of hepatobiliary imaging for differential diagnosis, AM J GASTRO, 95(5), 2000, pp. 1367-1368
Authors:
Prasch, F
Wogritsch, S
Hurtl, I
Holm, C
Najemnik, C
Dudczak, R
Citation: F. Prasch et al., Severe short-term hypothyroidism is not associated with an increased incidence of myocardial ischemia as assessed by thallium-201 stress/rest myocardial scintigraphy, THYROID, 9(2), 1999, pp. 155-158
Authors:
Flores, JA
Becherer, A
Czerny, C
Kaserer, K
Niederle, B
Dudczak, R
Citation: Ja. Flores et al., Impact of 18-fluor fluordesoxyglucose-positrone emissions tomography (PET)in the follow up of locally recurrent and/or distantly metastasizing thyroid cancer, ACT MED AUS, 26(4), 1999, pp. 117-117
Authors:
Prasch, F
Knosp, SE
Steinbach, R
Wogritsch, S
Hurtl, I
Greifeneder, M
Holm, C
Najemnik, C
Dudczak, R
Citation: F. Prasch et al., Hyperthyroidism caused by a TSH-secreting pituitary adenoma, ACT MED AUS, 26(1), 1999, pp. 32-36
Risultati:
1-16
|